More than 50 campaign groups have called on the Dutch cabinet to oppose plans by the European Commission to relax rules on ...
An update from Gain Therapeutics ( ($GANX) ) is now available. On December 18, 2025, Gain Therapeutics reported exploratory endpoint data from ...
The number of people diagnosed with Parkinson’s disease is increasing, with experts warning that cases are growing faster than Alzheimer’s disease. What’s behind ...
Explore dopamine's role in movement and how it challenges long-standing theories about motor control and Parkinson's disease ...
Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid (CSF), a prespecified endpoint The reduction in GluSph in CSF, a first-ever ...
Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid ...
UK trial has found that azathioprine does not slow progression in early Parkinson’s disease, despite good tolerability. The ...
In the brain, alpha-synuclein is known for forming clumps called Lewy bodies, which damage brain cells and lead to diseases ...
A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback